Impact BioMedical Inc. discovers, confirms and patents unique science and technologies resulting in new offerings in human healthcare and wellness. Impact BioMedical Inc. is based in NEW YORK.
| Revenue (Most Recent Fiscal Year) | $0.05M |
| Net Income (Most Recent Fiscal Year) | $-24.71M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | -- |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 0.88 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 0.27 |
| Pre-Tax Margin (Trailing 12 Months) | -- |
| Net Margin (Trailing 12 Months) | -- |
| Return on Equity (Trailing 12 Months) | -46.09% |
| Return on Assets (Trailing 12 Months) | -26.20% |
| Current Ratio (Most Recent Fiscal Quarter) | 0.22 |
| Quick Ratio (Most Recent Fiscal Quarter) | 0.17 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
| Inventory Turnover (Trailing 12 Months) | 0.00 |
| Book Value per Share (Most Recent Fiscal Quarter) | $0.56 |
| Earnings per Share (Most Recent Fiscal Quarter) | -- |
| Earnings per Share (Most Recent Fiscal Year) | -- |
| Diluted Earnings per Share (Trailing 12 Months) | -- |
| Exchange | NYSEMKT |
| Sector | Healthcare |
| Industry | Biotechnology |
| Common Shares Outstanding | 12.09M |
| Free Float | -- |
| Market Capitalization | $5.92M |
| Average Volume (Last 20 Days) | 10.48M |
| Beta (Past 60 Months) | -- |
| Percentage Held By Insiders (Latest Annual Proxy Report) | -- |
| Percentage Held By Institutions (Latest 13F Reports) | -- |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |